1. Home
  2. NMTC
  3. NMTC News

Latest NeuroOne Medical Technologies Corporation (NMTC) News on April 24, 2025

NeuroOne® Completes FDA Submission for the OneRF® Trigeminal Nerve Ablation System to Treat Facial Pain
NMTC

GlobeNewswire

a day ago

NeuroOne® Completes FDA Submission for the OneRF® Trigeminal Nerve Ablation System to Treat Facial Pain

NeuroOne® Issues Letter to Shareholders
NMTC

GlobeNewswire

8 days ago

NeuroOne® Issues Letter to Shareholders

NeuroOne® OneRF® Technology Success Story Featured on Fox News
NMTC

GlobeNewswire

10 days ago

NeuroOne® OneRF® Technology Success Story Featured on Fox News

Ronald McClurg Spends US$100k On NeuroOne Medical Technologies Stock
NMTC

Simply Wall St.

14 days ago

Ronald McClurg Spends US$100k On NeuroOne Medical Technologies Stock

NeuroOne Medical Technologies Corporation Announces Pricing of $8.0 Million Public Offering of Common Stock
NMTC

GlobeNewswire

20 days ago

NeuroOne Medical Technologies Corporation Announces Pricing of $8.0 Million Public Offering of Common Stock

NeuroOne Medical Technologies Corporation Announces Proposed Public Offering of Common Stock
NMTC

GlobeNewswire

21 days ago

NeuroOne Medical Technologies Corporation Announces Proposed Public Offering of Common Stock

NeuroOne® CEO Dave Rosa Discusses Epilepsy Treatment Innovations on Today’s Marketplace - Update
NMTC

GlobeNewswire

a month ago

NeuroOne® CEO Dave Rosa Discusses Epilepsy Treatment Innovations on Today’s Marketplace - Update

NeuroOne® CEO Dave Rosa Discusses Epilepsy Treatment Innovations on Today’s Marketplace
NMTC

GlobeNewswire

a month ago

NeuroOne® CEO Dave Rosa Discusses Epilepsy Treatment Innovations on Today’s Marketplace

NeuroOne CEO Joins Today’s Marketplace To Discuss The Latest Treatments for Epilepsy
NMTC

GlobeNewswire

a month ago

NeuroOne CEO Joins Today’s Marketplace To Discuss The Latest Treatments for Epilepsy

NeuroOne® Accelerates Timeline of 510(k) Submission to FDA for the OneRF® Trigeminal Nerve Ablation System to Treat Facial Pain
NMTC

GlobeNewswire

a month ago

NeuroOne® Accelerates Timeline of 510(k) Submission to FDA for the OneRF® Trigeminal Nerve Ablation System to Treat Facial Pain

NeuroOne® to Present at the Oppenheimer 35th Annual Healthcare MedTech & Services Conference
NMTC

GlobeNewswire

2 months ago

NeuroOne® to Present at the Oppenheimer 35th Annual Healthcare MedTech & Services Conference

NeuroOne® Reports First Quarter Fiscal Year 2025 Financial Results and Provides Corporate Update
NMTC

GlobeNewswire

2 months ago

NeuroOne® Reports First Quarter Fiscal Year 2025 Financial Results and Provides Corporate Update

NeuroOne® to Report First Quarter Fiscal Year 2025 Financial Results on Wednesday, February 12 at 8:30 a.m. Eastern Time
NMTC

GlobeNewswire

3 months ago

NeuroOne® to Report First Quarter Fiscal Year 2025 Financial Results on Wednesday, February 12 at 8:30 a.m. Eastern Time

NeuroOne® Regains Compliance with Nasdaq Listing Requirements
NMTC

GlobeNewswire

3 months ago

NeuroOne® Regains Compliance with Nasdaq Listing Requirements

NeuroOne Reports Record Revenue Boost in Q1 2025
NMTC

TipRanks

3 months ago

NeuroOne Reports Record Revenue Boost in Q1 2025

NeuroOne® Announces Preliminary Unaudited First Quarter Fiscal 2025 Revenue Increase to a Record $6.2 Million
NMTC

GlobeNewswire

3 months ago

NeuroOne® Announces Preliminary Unaudited First Quarter Fiscal 2025 Revenue Increase to a Record $6.2 Million

NeuroOne® Announces Change of Virtual Investor Webinar to Friday, January 10, 2024
NMTC

GlobeNewswire

4 months ago

NeuroOne® Announces Change of Virtual Investor Webinar to Friday, January 10, 2024

NeuroOne® Announces Virtual Investor Webinar on January 9, 2025 at 11:00 a.m. EST
NMTC

GlobeNewswire

4 months ago

NeuroOne® Announces Virtual Investor Webinar on January 9, 2025 at 11:00 a.m. EST

NeuroOne® Product Revenue Increases 77% to $3.5 Million in Fiscal 2024: Expects Product Revenue to Increase at Least 132% to at Least $8 Million in Fiscal 2025
NMTC

GlobeNewswire

4 months ago

NeuroOne® Product Revenue Increases 77% to $3.5 Million in Fiscal 2024: Expects Product Revenue to Increase at Least 132% to at Least $8 Million in Fiscal 2025

NeuroOne® to Report Fourth Quarter and Fiscal Year 2024 Financial Results on December 17 at 9:00 a.m. Eastern Time
NMTC

GlobeNewswire

5 months ago

NeuroOne® to Report Fourth Quarter and Fiscal Year 2024 Financial Results on December 17 at 9:00 a.m. Eastern Time

Winter 2024 Investor Summit Virtual: Q4 Presentations Now Available for On-Demand Viewing
NMTC

ACCESSWIRE

5 months ago

Winter 2024 Investor Summit Virtual: Q4 Presentations Now Available for On-Demand Viewing

NeuroOne Medical Technologies Corporation to Present at November 21st Virtual Investor Summit Microcap Event
NMTC

ACCESSWIRE

5 months ago

NeuroOne Medical Technologies Corporation to Present at November 21st Virtual Investor Summit Microcap Event

NeuroOne® Announces Expansion of Existing Distribution Agreement with Zimmer Biomet for Commercialization of OneRF™ Ablation System
NMTC

GlobeNewswire

6 months ago

NeuroOne® Announces Expansion of Existing Distribution Agreement with Zimmer Biomet for Commercialization of OneRF™ Ablation System

NeuroOne® Medical Technologies to Present at the 2024 ThinkEquity Conference
NMTC

GlobeNewswire

6 months ago

NeuroOne® Medical Technologies to Present at the 2024 ThinkEquity Conference

NeuroOne® Spinal Cord Stimulation Electrode Technology to be Featured at The Business of Pain Conference
NMTC

GlobeNewswire

7 months ago

NeuroOne® Spinal Cord Stimulation Electrode Technology to be Featured at The Business of Pain Conference

NeuroOne® Announces Breakthrough Case Completed with OneRF™ Ablation System at the University Hospitals in Cleveland
NMTC

GlobeNewswire

7 months ago

NeuroOne® Announces Breakthrough Case Completed with OneRF™ Ablation System at the University Hospitals in Cleveland

NeuroOne® to Present at the H.C. Wainwright 26th Annual Global Investment Conference
NMTC

GlobeNewswire

8 months ago

NeuroOne® to Present at the H.C. Wainwright 26th Annual Global Investment Conference

NeuroOne® Reports Third Quarter Fiscal Year 2024 Financial Results and Provides Corporate Update
NMTC

GlobeNewswire

8 months ago

NeuroOne® Reports Third Quarter Fiscal Year 2024 Financial Results and Provides Corporate Update

NeuroOne® to Report Third Quarter Fiscal Year 2024 Financial Results and Provide Corporate Update on August 14
NMTC

GlobeNewswire

8 months ago

NeuroOne® to Report Third Quarter Fiscal Year 2024 Financial Results and Provide Corporate Update on August 14

NeuroOne® Announces $2.65 Million Equity Financing And $3.0 Million Credit Facility
NMTC

GlobeNewswire

9 months ago

NeuroOne® Announces $2.65 Million Equity Financing And $3.0 Million Credit Facility

NeuroOne® Announces First in Human Ablations Completed with OneRF™ Ablation System
NMTC

GlobeNewswire

10 months ago

NeuroOne® Announces First in Human Ablations Completed with OneRF™ Ablation System

NeuroOne® Granted Approval of ICD-10 Procedure Code for sEEG RF Ablation
NMTC

GlobeNewswire

10 months ago

NeuroOne® Granted Approval of ICD-10 Procedure Code for sEEG RF Ablation

NeuroOne® Reports Second Quarter Fiscal Year 2024 Financial Results and Provides Corporate Update
NMTC

GlobeNewswire

a year ago

NeuroOne® Reports Second Quarter Fiscal Year 2024 Financial Results and Provides Corporate Update

NeuroOne® to Report Second Quarter Fiscal Year 2024 Financial Results and Provide Corporate Update on May 14
NMTC

GlobeNewswire

a year ago

NeuroOne® to Report Second Quarter Fiscal Year 2024 Financial Results and Provide Corporate Update on May 14

Favourable Signals For NeuroOne Medical Technologies: Numerous Insiders Acquired Stock
NMTC

Simply Wall St.

a year ago

Favourable Signals For NeuroOne Medical Technologies: Numerous Insiders Acquired Stock

NeuroOne® CEO Dave Rosa Featured on Bloomberg Technology
NMTC

GlobeNewswire

a year ago

NeuroOne® CEO Dave Rosa Featured on Bloomberg Technology

NeuroOne® Announces First Implant of OneRF™ Ablation Electrodes
NMTC

GlobeNewswire

a year ago

NeuroOne® Announces First Implant of OneRF™ Ablation Electrodes

NeuroOne® CEO Dave Rosa Featured on Fox Business Network’s Varney & Co.
NMTC

GlobeNewswire

a year ago

NeuroOne® CEO Dave Rosa Featured on Fox Business Network’s Varney & Co.

NeuroOne® Initiates Limited Commercial Launch of OneRF™ Ablation System
NMTC

GlobeNewswire

a year ago

NeuroOne® Initiates Limited Commercial Launch of OneRF™ Ablation System

NeuroOne® to Participate in the 36th Annual Roth Conference
NMTC

GlobeNewswire

a year ago

NeuroOne® to Participate in the 36th Annual Roth Conference

NeuroOne Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
NMTC

GlobeNewswire

a year ago

NeuroOne Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

NeuroOne Medical Technologies First Quarter 2024 Earnings: Revenues Beat Expectations, EPS In Line
NMTC

Simply Wall St.

a year ago

NeuroOne Medical Technologies First Quarter 2024 Earnings: Revenues Beat Expectations, EPS In Line

NeuroOne® Reports First Quarter Fiscal Year 2024 Financial Results and Provides Corporate Update
NMTC

GlobeNewswire

a year ago

NeuroOne® Reports First Quarter Fiscal Year 2024 Financial Results and Provides Corporate Update

NeuroOne® to Report First Quarter Fiscal Year 2024 Financial Results and Provide Corporate Update on February 13
NMTC

GlobeNewswire

a year ago

NeuroOne® to Report First Quarter Fiscal Year 2024 Financial Results and Provide Corporate Update on February 13

HBT Financial (HBT) Reports Q4 Earnings: What Key Metrics Have to Say
NMTC

Zacks

a year ago

HBT Financial (HBT) Reports Q4 Earnings: What Key Metrics Have to Say

Myomo Announces Closing of $6 Million Registered Direct Offering of Common Stock Priced At-the-Market
NMTC

Business Wire

a year ago

Myomo Announces Closing of $6 Million Registered Direct Offering of Common Stock Priced At-the-Market

Spero Therapeutics, Inc. (NASDAQ:SPRO): Are Analysts Optimistic?
NMTC

Simply Wall St.

a year ago

Spero Therapeutics, Inc. (NASDAQ:SPRO): Are Analysts Optimistic?

Issuer Direct Set to Exhibit and Sponsor the 2024 Vancouver Resource Investment Conference
NMTC

ACCESSWIRE

a year ago

Issuer Direct Set to Exhibit and Sponsor the 2024 Vancouver Resource Investment Conference

Presenting on Emerging Growth Conference 66 Day 2 on January 11 Register to Stream
NMTC

GlobeNewswire

a year ago

Presenting on Emerging Growth Conference 66 Day 2 on January 11 Register to Stream

Acrivon Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference
NMTC

GlobeNewswire

a year ago

Acrivon Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference

Blue Hat Announces Financial Results for the First Half of 2023, Highlighted by 5,657.93% Increase in Revenues to $46.30 million
NMTC

GlobeNewswire

a year ago

Blue Hat Announces Financial Results for the First Half of 2023, Highlighted by 5,657.93% Increase in Revenues to $46.30 million

New partnership aims to advance vaccine against MERS coronavirus
NMTC

GlobeNewswire

a year ago

New partnership aims to advance vaccine against MERS coronavirus

The 3 Most Undervalued Penny Stocks to Buy in December
NMTC

InvestorPlace

a year ago

The 3 Most Undervalued Penny Stocks to Buy in December

NeuroOne® Reports Fiscal Fourth Quarter and Full Fiscal Year 2023 Financial Results and Provides Corporate Update
NMTC

GlobeNewswire

a year ago

NeuroOne® Reports Fiscal Fourth Quarter and Full Fiscal Year 2023 Financial Results and Provides Corporate Update

Kustom Entertainment Inc. and Clover Leaf Capital Corp. Amend the Lock-Up Agreement in their Proposed Business Combination
NMTC

GlobeNewswire

a year ago

Kustom Entertainment Inc. and Clover Leaf Capital Corp. Amend the Lock-Up Agreement in their Proposed Business Combination

NeuroOne® Receives FDA 510(k) Clearance to Market its OneRF™ Ablation System
NMTC

GlobeNewswire

a year ago

NeuroOne® Receives FDA 510(k) Clearance to Market its OneRF™ Ablation System

NeuroOne® to Report Fourth Quarter and Fiscal Year 2023 Financial Results and Provide Corporate Update on December 14
NMTC

GlobeNewswire

a year ago

NeuroOne® to Report Fourth Quarter and Fiscal Year 2023 Financial Results and Provide Corporate Update on December 14

Sidoti Events, LLC's Virtual December Small-Cap Conference
NMTC

ACCESSWIRE

a year ago

Sidoti Events, LLC's Virtual December Small-Cap Conference

Here's Why We're Watching BriaCell Therapeutics' (TSE:BCT) Cash Burn Situation
NMTC

Simply Wall St.

a year ago

Here's Why We're Watching BriaCell Therapeutics' (TSE:BCT) Cash Burn Situation

25 Highest Quality Furniture Brands in the World
NMTC

Insider Monkey

a year ago

25 Highest Quality Furniture Brands in the World

NeuroOne® Announces Patent Allowance for Drug Delivery Utilizing a Novel Neural Probe
NMTC

GlobeNewswire

a year ago

NeuroOne® Announces Patent Allowance for Drug Delivery Utilizing a Novel Neural Probe

NeuroOne® Appoints Medtech Executive Christopher R. Volker as Chief Operating Officer and Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
NMTC

GlobeNewswire

a year ago

NeuroOne® Appoints Medtech Executive Christopher R. Volker as Chief Operating Officer and Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Avadel Pharmaceuticals plc (NASDAQ:AVDL) Q3 2023 Earnings Call Transcript
NMTC

Insider Monkey

a year ago

Avadel Pharmaceuticals plc (NASDAQ:AVDL) Q3 2023 Earnings Call Transcript

METALLA REPORTS FINANCIAL RESULTS FOR THE THIRD QUARTER OF 2023 AND PROVIDES ASSET UPDATES
NMTC

CNW Group

a year ago

METALLA REPORTS FINANCIAL RESULTS FOR THE THIRD QUARTER OF 2023 AND PROVIDES ASSET UPDATES

Manhattan Bridge Capital's (NASDAQ:LOAN) investors will be pleased with their 18% return over the last five years
NMTC

Simply Wall St.

a year ago

Manhattan Bridge Capital's (NASDAQ:LOAN) investors will be pleased with their 18% return over the last five years

NeuroOne® Provides Progress Update on FDA 510(k) Submission for OneRF™ Ablation System
NMTC

GlobeNewswire

a year ago

NeuroOne® Provides Progress Update on FDA 510(k) Submission for OneRF™ Ablation System

Karyopharm Therapeutics Inc. (NASDAQ:KPTI) Q3 2023 Earnings Call Transcript
NMTC

Insider Monkey

a year ago

Karyopharm Therapeutics Inc. (NASDAQ:KPTI) Q3 2023 Earnings Call Transcript

Share on Social Networks: